VantAI Unveils Neo-1, the First AI Model for

VantAI Unveils Neo-1, the First AI Model for Rewiring Molecular Interactions in Therapeutic Design

VantAI Unveils Neo-1: A Groundbreaking AI Model for Revolutionary Drug Design VantAI, a cutting-edge biotechnology company, has unveiled Neo-1, a pioneering AI model that is set to transform the future of drug development. Announced at the NVIDIA GTC 2025 conference,…

Read MoreVantAI Unveils Neo-1, the First AI Model for Rewiring Molecular Interactions in Therapeutic Design
iECURE to Present Full Data for First Infant Dosed with ECUR-506 in OTC-HOPE Trial at 2025 ACMG Annual Meeting

iECURE to Present Full Data for First Infant Dosed with ECUR-506 in OTC-HOPE Trial at 2025 ACMG Annual Meeting

iECURE Presents Promising Data for ECUR-506 in OTC-HOPE Phase 1/2 Trial at 2025 ACMG Annual Meeting iECURE, Inc., a gene editing company focused on developing mutation-agnostic in vivo gene insertion therapies for liver disorders, has shared encouraging results from the…

Read MoreiECURE to Present Full Data for First Infant Dosed with ECUR-506 in OTC-HOPE Trial at 2025 ACMG Annual Meeting
Almirall's 16th Skin Academy Unites Experts to Advance Skin Science and Treatments

Almirall’s 16th Skin Academy Unites Experts to Advance Skin Science and Treatments

Almirall’s 16th Skin Academy: Advancing Dermatological Care Through Global Collaboration Almirall’s 16th edition of the Skin Academy presents a unique opportunity to foster collaboration among leading experts in medical dermatology. This prestigious event brings together top-tier clinicians, researchers, and healthcare…

Read MoreAlmirall’s 16th Skin Academy Unites Experts to Advance Skin Science and Treatments
GE HealthCare has announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, a groundbreaking 3D ultrasound system designed to enhance breast cancer detection in women with dense breast tissue.

GE HealthCare Unveils AI-Powered Invenia ABUS Premium for Early Cancer Detection

GE HealthCare Launches AI-Powered Invenia ABUS Premium for Faster, More Accurate Cancer Detection in Dense Breasts Introduction GE HealthCare has announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, a groundbreaking 3D ultrasound system designed to enhance breast cancer…

Read MoreGE HealthCare Unveils AI-Powered Invenia ABUS Premium for Early Cancer Detection
Verasonics Introduces New Features for Vantage® NXT Ultrasound System

Verasonics Updates Vantage® NXT Ultrasound System with SDK Model and 3 MHz Transducer

Verasonics Introduces New Features for Vantage® NXT Ultrasound System Introduction Verasonics, Inc., a leader in research ultrasound, has announced a significant update to its Vantage NXT Research Ultrasound System, designed to enhance ultrasound research and product development. This update, available…

Read MoreVerasonics Updates Vantage® NXT Ultrasound System with SDK Model and 3 MHz Transducer
Precision BioSciences Presents Preclinical Data on PBGENE-HBV for Chronic Hepatitis B

Precision BioSciences Presents Preclinical Data on PBGENE-HBV for Chronic Hepatitis B Cure at Global Hepatitis Summit 2025

Precision BioSciences Presents Preclinical Data on PBGENE-HBV at Global Hepatitis Summit 2025 Introduction Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company known for its novel ARCUS® platform, has unveiled promising preclinical data supporting the use of repeat dosing…

Read MorePrecision BioSciences Presents Preclinical Data on PBGENE-HBV for Chronic Hepatitis B Cure at Global Hepatitis Summit 2025
ICON First CRO to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management

ICON First CRO to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management

ICON Integrates Medidata Clinical Data Studio to Enhance Clinical Trial Efficiency Introduction Medidata, a Dassault Systèmes brand and a global leader in clinical trial solutions, has announced that ICON plc, a leading clinical research organization (CRO), will be integrating the…

Read MoreICON First CRO to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management